Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease.

Literature DB >> 12574296

Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease.

Jürgen H Helbig¹, Søren A Uldum, Sverker Bernander, Paul Christian Lück, Günther Wewalka, Bill Abraham, Valeria Gaia, Timothy G Harrison.

Abstract

The clinical utility of Legionella urinary antigen assays for the diagnosis of Legionnaires' disease was assessed by using samples from 317 culture-proven cases. The sensitivities of the Binax enzyme immunoassay (EIA) and Biotest EIA were found to be 93.7 and 94.4% for travel-associated infection and 86.5 and 76.0% for community-acquired infection but only 44.2 and 45.7% for nosocomially acquired infection, respectively.

Entities: Disease

Mesh：

Substances：
Antigens, Bacterial

Year: 2003 PMID： 12574296 PMCID： PMC149701 DOI： 10.1128/JCM.41.2.838-840.2003

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

15 in total

1. Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA.

Authors: Jürgen H Helbig; Søren A Uldum; P Christian Lück; Timothy G Harrison
Journal: J Med Microbiol Date: 2001-06 Impact factor: 2.472

2. Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains.

Authors: E Dournon; W F Bibb; P Rajagopalan; N Desplaces; R M McKinney
Journal: J Infect Dis Date: 1988-03 Impact factor: 5.226

3. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

Authors: J F Plouffe; T M File; R F Breiman; B A Hackman; S J Salstrom; B J Marston; B S Fields
Journal: Clin Infect Dis Date: 1995-05 Impact factor: 9.079

4. Nosocomial Legionnaires' disease in England and Wales, 1980-92.

Authors: C A Joseph; J M Watson; T G Harrison; C L Bartlett
Journal: Epidemiol Infect Date: 1994-04 Impact factor: 2.451

5. The impact of diagnosis by legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease.

Authors: N Formica; M Yates; M Beers; J Carnie; G Hogg; N Ryan; G Tallis
Journal: Epidemiol Infect Date: 2001-10 Impact factor: 2.451

6. Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups.

Authors: J H Helbig; J B Kurtz; M C Pastoris; C Pelaz; P C Lück
Journal: J Clin Microbiol Date: 1997-11 Impact factor: 5.948

Review 7. Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist.

Authors: D E Craven; K A Steger
Journal: Infect Control Hosp Epidemiol Date: 1997-11 Impact factor: 3.254

8. Discrimination between clinical and environmental strains of Legionella pneumophila by a monoclonal antibody.

Authors: W Ehret; B U von Specht; G Ruckdeschel
Journal: Isr J Med Sci Date: 1986-10

Review 9. Legionella and Legionnaires' disease: 25 years of investigation.

Authors: Barry S Fields; Robert F Benson; Richard E Besser
Journal: Clin Microbiol Rev Date: 2002-07 Impact factor: 26.132

10. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1.

Authors: P J Dennis; J V Lee
Journal: J Appl Bacteriol Date: 1988-08

41 in total

1. Contribution of amoebic coculture to recovery of Legionella isolates from respiratory samples: prospective analysis over a period of 32 months.

Authors: G Descours; A Suet; C Ginevra; C Campese; S Slimani; F Ader; D Che; G Lina; S Jarraud
Journal: J Clin Microbiol Date: 2012-02-08 Impact factor: 5.948

2. Utility of PCR, Culture, and Antigen Detection Methods for Diagnosis of Legionellosis.

Authors: Derrick J Chen; Gary W Procop; Sherilynn Vogel; Belinda Yen-Lieberman; Sandra S Richter
Journal: J Clin Microbiol Date: 2015-08-19 Impact factor: 5.948

3. Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires' disease.

Authors: M Mentasti; N K Fry; B Afshar; C Palepou-Foxley; F C Naik; T G Harrison
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-01-26 Impact factor: 3.267

4. Value of serological testing for diagnosis of legionellosis in outbreak patients.

Authors: Almudena Rojas; M Dolores Navarro; Francisca E Fornés; Estefanía Serra; Encarnación Simarro; José Rojas; Joaquín Ruiz
Journal: J Clin Microbiol Date: 2005-08 Impact factor: 5.948

Review 5. [Pneumonia - pathogen-based or constellation-based therapy?].

Authors: A Kuhnke; T Welte; N Suttorp
Journal: Internist (Berl) Date: 2006-06 Impact factor: 0.743

6. Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.

Authors: Rosa Bellmann-Weiler; Mathias Ausserwinkler; Katharina Kurz; Igor Theurl; Guenter Weiss
Journal: J Clin Microbiol Date: 2010-03-10 Impact factor: 5.948

7. Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates.

Authors: S S Kashino; C Abeijon; L Qin; K A Kanunfre; F S Kubrusly; F O Silva; D L Costa; D Campos; C H N Costa; I Raw; A Campos-Neto
Journal: Parasite Immunol Date: 2012-07 Impact factor: 2.280